Protocols - Hemorio

-
LABORATORIAL TESTS
EVERY 4 MONTHS - Complete blood test + reticulocyte +SAE
- Glycemia, hepatic, electrolyte and renal function tests
EVERY YEAR
- Serology (hepatitis B,C, HIV, HTLV, Sifilis, Chagas
Disease)
- Ferritin
- Immunohaematological study
- Pulse oximeter
- 24 hour-proteinuria and creatinine clearance
- Lipidogram
EVERY 6 MONTHS ON
TRANSFUNDED
PATIENTS
EVERY 5 YEARS
- Dosage (ferritine, erythropoietin (from 3 years), hemoglobin F (pts up to 15 years
or HU usage) and serum Folate
- Evaluation to detect alloantibodies
- TAP and PTT
- Fecal Parasitology
- Dosage of hemoglobin F (in patients older than 15 years)
SPECIALS EXAMS
- Odontological Evaluation
EVERY 6 MONTHS
- Nursing Evaluation – aiming at general guiding, with special focus on legs ulcers prevention.
- 10 years – Cardiologic Evaluation (Echocardiogram and follow-up at the cardiologist
discretion)
- 10 years – Ophthalmologic Evaluation – annual on SC patients and on those using
EVERY YEAR
Deferoxamine; every 2 years in other
- 02 years – Neurological evaluation – Transcranial Doppler, up to 20 years and follow-up at
Neurology discretion
- Physiatrist Evaluation
EVERY 2 YEARS - Abdominal ultrasound
- Nutritional Evaluation – treatment as necessary (For ex: hyperuricemia)
EVERY 5 YEARS - Audiometry (1st evaluation at 7 years)
Note.: The intervals between consultation and exams are related to patients without intercurrence. So,
these intervals may be shortened depending on the presented necessity by the patient.
3. SPECIAL CLINICAL SITUATIONS
IMUNIZATION: In addition to follow the vaccine calendar, please introduce the following scheme:
2 MONTHS - Prevenar (pneumo 7)
3 MONTHS - Meningococcal Conjugate C
4 MONTHS - Prevenar (pneumo 7)
6 MONTHS - Prevenar (pneumo 7)
6 MONTHS - Influenza (flu)
12 MONTHS - Varicella and Hepatitis A
15 MONTHS - Prevenar (pneumo 7)
2 YEARS - Pneumo 23
4 – 6 YEARS
- Reinforcement with Bacterial Triple (DTP or DTPa)
- Triple viral
5 YEARS - Pneumo 23
14 – 16 YEARS - Double type adult
IN THE BEGINNING
OF THE
- Hepatitis A (HAV-G negative patients)
9